PNC Financial Services Group
CKPT

PNC Financial Services Group’s Checkpoint Therapeutics CKPT Stock Holding History

PNC Financial Services Group’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-408
Closed -$13K – 4541
2021
Q4 		$13K Hold
408
– – ﹤0.01% 3699
2021
Q3 		$13K Hold
408
– – ﹤0.01% 3664
2021
Q2 		$12K Hold
408
– – ﹤0.01% 3641
2021
Q1 		$13K Hold
408
– – ﹤0.01% 3565
2020
Q4 		$11K Hold
408
– – ﹤0.01% 3534
2020
Q3 		$11K Hold
408
– – ﹤0.01% 3466
2020
Q2 		$8K Buy
+408
New +$7.43K ﹤0.01% 3520

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PNC Financial Services Group's CKPT Position: Q1 2022 in Review

PNC Financial Services Group sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 408 shares — an estimated $13K sold.

PNC Financial Services Group first reported a position in CKPT in Q2 2020 and held it in 7 quarters. The position peaked at $13K in Q4 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.

  • PNC Financial Services Group reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 408 Checkpoint Therapeutics shares in Q1 2022, an estimated $13K.
  • PNC Financial Services Group first reported a position in Checkpoint Therapeutics in Q2 2020 and held it in 7 quarters.
  • PNC Financial Services Group's Checkpoint Therapeutics position peaked at $13K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.

Based on PNC Financial Services Group's 13F filing for Q1 2022, filed 12 May 2022.